Red List

CUECue Biopharma, Inc.

Healthcare · Biotechnology · micro-cap ($120M)
-33.0%
from rolling 252-day high of $45.50 set 2026-07-10 · 61d ago
Current
$30.50
Decline depth
-33.0%
Decline σ
1.6σ
TFC
1/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$CUE landed on the list 2026-04-24, down 42.7% from its 52-week high that day — now down -33.0%.

It has clawed back 41.4 percentage points off that level. It bottomed 59.7% below that high along the way.

From the 52-week high as of 2026-04-24 to today. Split-adjusted. Observed, not a forecast.

Structural break signals

CUE qualifies for the Red List on decline depth.

Decline depth
-33.0%
From rolling 252-day high of $45.50, 61d ago. Past the 30% Amber threshold.
Time-frame continuity
1/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
1.6σ
Drop over the last 20 bars in units of daily volatility (8.17%/day).

The structural read

What price action says about CUE.

CUE qualifies for the Red List on decline depth — down -33.0% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.

Questions about CUE

What people ask.

Why is CUE on Broken Stocks?

CUE qualifies for the Red List on decline depth. It is down -33.0% from its rolling 252-day high of $45.50, set on 2026-07-10 — 61d ago.

Is CUE a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. CUE is down -33.0% from its 52-week high of $45.50, set 61d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is CUE a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CUE trading inside its 52-week range?

At $30.50, CUE sits 70.0% of the way from its 52-week low ($4.98) to its 52-week high ($41.42). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CUE been declining?

The current 33.0% decline accrued over 61d, which annualizes to roughly -197.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CUE compare to its sector?

There are 276 other Healthcare tickers on Broken Stocks: 134 Red, 81 Amber, 61 Watch, with 34 showing recovering structural signals. Median sector decline is -35.2% — CUE's decline is shallower than the sector median.